XML 20 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Unaudited Condensed Consolidated Statements of Shareholders’ Equity - USD ($)
$ in Thousands
Total
Class A common stock
Class B convertible common stock
Common Stock
Class A common stock
Common Stock
Class B convertible common stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Treasury stock
Beginning balance of common stock (in shares) at Dec. 31, 2022       29,257,651 70,032,694        
Beginning balance at Dec. 31, 2022 $ 455,613     $ 293 $ 700 $ 631,908 $ (135,674) $ (10,647) $ (30,967)
Beginning balance (in shares) at Dec. 31, 2022                 1,649,931
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock for settlement of equity awards (in shares)       246,537          
Issuance of common stock for settlement of equity awards 209     $ 2   207      
Shares withheld related to net share settlement (in shares)       (14,293)          
Shares withheld related to net share settlement (257)         (257)      
Repurchase of common stock (in shares)                 389,801
Repurchase of common stock (6,374)               $ (6,374)
Stock-based compensation expense 13,464         13,464      
Net income 9,509           9,509    
Other comprehensive income (loss) 3,591             3,591  
Ending balance of common stock (in shares) at Mar. 31, 2023       29,489,895 70,032,694        
Ending balance at Mar. 31, 2023 475,755     $ 295 $ 700 645,322 (126,165) (7,056) $ (37,341)
Ending balance (in shares) at Mar. 31, 2023                 2,039,732
Beginning balance of common stock (in shares) at Dec. 31, 2022       29,257,651 70,032,694        
Beginning balance at Dec. 31, 2022 455,613     $ 293 $ 700 631,908 (135,674) (10,647) $ (30,967)
Beginning balance (in shares) at Dec. 31, 2022                 1,649,931
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 19,641                
Ending balance of common stock (in shares) at Jun. 30, 2023       29,804,225 70,032,694        
Ending balance at Jun. 30, 2023 458,799     $ 298 $ 700 660,256 (116,033) (10,743) $ (75,679)
Ending balance (in shares) at Jun. 30, 2023                 5,263,015
Beginning balance of common stock (in shares) at Mar. 31, 2023       29,489,895 70,032,694        
Beginning balance at Mar. 31, 2023 475,755     $ 295 $ 700 645,322 (126,165) (7,056) $ (37,341)
Beginning balance (in shares) at Mar. 31, 2023                 2,039,732
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock for settlement of equity awards (in shares)       338,035          
Issuance of common stock for settlement of equity awards 190     $ 3   187      
Shares withheld related to net share settlement (in shares)       (23,705)          
Shares withheld related to net share settlement (293)         (293)      
Repurchase of common stock (in shares)                 3,223,283
Repurchase of common stock (38,338)               $ (38,338)
Stock-based compensation expense 15,040         15,040      
Net income 10,132           10,132    
Other comprehensive income (loss) (3,687)             (3,687)  
Ending balance of common stock (in shares) at Jun. 30, 2023       29,804,225 70,032,694        
Ending balance at Jun. 30, 2023 458,799     $ 298 $ 700 660,256 (116,033) (10,743) $ (75,679)
Ending balance (in shares) at Jun. 30, 2023                 5,263,015
Beginning balance of common stock (in shares) at Dec. 31, 2023   18,725,947 70,032,694 30,522,570 70,032,694        
Beginning balance at Dec. 31, 2023 $ 440,711     $ 305 $ 700 683,117 (89,984) (9,551) $ (143,876)
Beginning balance (in shares) at Dec. 31, 2023 11,796,623               11,796,623
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock for settlement of equity awards (in shares)       620,835          
Issuance of common stock for settlement of equity awards $ 195     $ 6   189      
Shares withheld related to net share settlement (in shares)       (122,480)          
Shares withheld related to net share settlement (1,574)     $ (1)   (1,573)      
Repurchase of common stock (in shares)                 285,611
Repurchase of common stock (3,379)               $ (3,379)
Stock-based compensation expense 10,235         10,235      
Net income 11,714           11,714    
Other comprehensive income (loss) (3,308)             (3,308)  
Ending balance of common stock (in shares) at Mar. 31, 2024       31,020,925 70,032,694        
Ending balance at Mar. 31, 2024 454,594     $ 310 $ 700 691,968 (78,270) (12,859) $ (147,255)
Ending balance (in shares) at Mar. 31, 2024                 12,082,234
Beginning balance of common stock (in shares) at Dec. 31, 2023   18,725,947 70,032,694 30,522,570 70,032,694        
Beginning balance at Dec. 31, 2023 $ 440,711     $ 305 $ 700 683,117 (89,984) (9,551) $ (143,876)
Beginning balance (in shares) at Dec. 31, 2023 11,796,623               11,796,623
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income $ 24,312                
Ending balance of common stock (in shares) at Jun. 30, 2024   18,596,409 70,032,694 31,703,199 70,032,694        
Ending balance at Jun. 30, 2024 $ 460,193     $ 317 $ 700 704,438 (65,672) (20,576) $ (159,014)
Ending balance (in shares) at Jun. 30, 2024 13,106,790               13,106,790
Beginning balance of common stock (in shares) at Mar. 31, 2024       31,020,925 70,032,694        
Beginning balance at Mar. 31, 2024 $ 454,594     $ 310 $ 700 691,968 (78,270) (12,859) $ (147,255)
Beginning balance (in shares) at Mar. 31, 2024                 12,082,234
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock for settlement of equity awards (in shares)       722,711          
Issuance of common stock for settlement of equity awards 1,856     $ 7   1,849      
Shares withheld related to net share settlement (in shares)       (40,437)          
Shares withheld related to net share settlement (500)         (500)      
Repurchase of common stock (in shares)                 1,024,556
Repurchase of common stock (11,759)               $ (11,759)
Stock-based compensation expense 11,121         11,121      
Net income 12,598           12,598    
Other comprehensive income (loss) (7,717)             (7,717)  
Ending balance of common stock (in shares) at Jun. 30, 2024   18,596,409 70,032,694 31,703,199 70,032,694        
Ending balance at Jun. 30, 2024 $ 460,193     $ 317 $ 700 $ 704,438 $ (65,672) $ (20,576) $ (159,014)
Ending balance (in shares) at Jun. 30, 2024 13,106,790               13,106,790